Newport News Public Library

The Duchess of York, Sarah Ferguson, Taps CYPFER as Chief Digital Security Advisor as Global Business Booms

Retrieved on: 
Tuesday, June 6, 2023

TORONTO and MIAMI, June 6, 2023 /PRNewswire/ -- The office of The Duchess of York, Sarah Ferguson, announced today the appointment of cyber security pioneer, Mr. Daniel Tobok, CEO CYPFER, to lead digital security efforts across global platforms.

Key Points: 
  • Sarah, Duchess of York, is a bestselling author, television personality, dedicated philanthropist, and a former member of the British royal family.
  • Sarah has been instrumentally involved with several charities as a patron and spokesperson, primarily focusing on helping cancer patients and children.
  • "I trust CYPFER for all of my digital security needs," Duchess shared.
  • With CYPFER I always know my digital needs are protected and I am in good hands."

EQS-News: European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2022

Retrieved on: 
Friday, March 24, 2023

EQS-News: European Healthcare Acquisition & Growth Company B.V.

Key Points: 
  • EQS-News: European Healthcare Acquisition & Growth Company B.V.
    European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2022 (news with additional features)
    The issuer is solely responsible for the content of this announcement.
  • European Healthcare Acquisition & Growth Company B.V. publishes its annual report for the financial year 2022
    Today, European Healthcare Acquisition & Growth Company B.V. ("EHC"), a Dutch operators-led special purpose acquisition company listed on Euronext Amsterdam that announced on 22 December 2022 that it signed a business combination agreement with Austrian-based Croma-Pharma GmbH, publishes its annual report for the financial year 2022 (the "Annual Report 2022"), including its financial statements and the report of its board.
  • The Annual Report 2022 relates to the financial year 2022, from 1 January 2022 to 31 December 2022, a period prior to completion of the proposed business combination of EHC with Croma-Pharma GmbH.
  • The Annual Report 2022 therefore does not comprise any accounts or results of Croma-Pharma GmbH.

DGAP-News: ​​​​​​​European Healthcare Acquisition & Growth Company B.V. retracts notice regarding reconvening its annual general meeting of shareholders

Retrieved on: 
Tuesday, May 31, 2022

DGAP-News: European Healthcare Acquisition & Growth Company B.V.

Key Points: 
  • DGAP-News: European Healthcare Acquisition & Growth Company B.V.
    European Healthcare Acquisition & Growth Company B.V. retracts notice regarding reconvening its annual general meeting of shareholders (news with additional features)
    The issuer is solely responsible for the content of this announcement.
  • European Healthcare Acquisition & Growth Company B.V. retracts notice regarding reconvening its annual general meeting of shareholders
    Today, European Healthcare Acquisition & Growth Company B.V. ("EHC"), a Dutch operators-led special purpose acquisition company listed on Euronext Amsterdam aiming to acquire one or more companies in the European healthcare sector, has retracted the notice of the annual general meeting of shareholders 2022 of EHC dated 19 May 2022.
  • Therefore, the annual general meeting 2022 of EHC will be held on the originally scheduled date of 23 June 2022 at 10:00 CEST, by means of a virtual meeting ("AGM").
  • European Healthcare Acquisition & Growth Company B.V.